Avience Biomedicals Ltd vs Rainbow Childrens Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Rainbow Childrens Medicare Ltd changed from 35.2 on March 2023 to 42.4 on March 2026 . This represents a CAGR of 4.76% over 4 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Rainbow Childrens Medicare Ltd changed from ₹ 7412 crore on March 2023 to ₹ 11814 crore on March 2026 . This represents a CAGR of 12.36% over 4 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 482.7 crore as compare to the Mar '26 revenue of ₹ 464.97 crore. This represent the growth of 3.81% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 147.36 crore as compare to the Mar '26 ebitda of ₹ 148.23 crore. This represent the decline of -0.59% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Rainbow Childrens Medicare Ltd changed from ₹ 39.73 crore to ₹ 62.54 crore over 9 quarters. This represents a CAGR of 22.34% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Rainbow Childrens Medicare Ltd changed from 13.22 % on March 2022 to 14.22 % on March 2026 . This represents a CAGR of 1.47% over 5 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana.
Subsequently, the Company converted into a Public Limited, and name of the Company was changed to Rainbow Children's Medicare Limited' via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 23 hospitals and 5 outpatient clinic centers across 9 cities, with a total bed capacity of 2,375 beds.
The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services.
Its Pediatric Services include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric Quaternary care (including multi-organ transplants); whereas, Obstetrics & Gynecology services include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility treatment.

FAQs for the comparison of Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Rainbow Childrens Medicare Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Rainbow Childrens Medicare Ltd is 11,876 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd?

The stock performance of Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Rainbow Childrens Medicare Ltd stock price is INR ₹1169.3.

How do dividend payouts of Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Rainbow Childrens Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.